Mobileye Global Inc (MBLY) does not present a compelling long-term buy opportunity for a beginner investor at this moment. The stock is under significant pressure from insider selling, bearish technical indicators, and mixed to negative analyst sentiment. While recent positive news about a contract with a major automaker provides some optimism, the financial performance and guidance suggest near-term headwinds. Given the user's preference for long-term investments and the lack of strong proprietary trading signals, it is advisable to hold off on buying this stock for now.
The technical indicators for MBLY are bearish. The MACD is negatively expanding, the RSI is neutral but leaning towards oversold territory, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The current price is close to the key support level of 6.941, but the overall trend does not suggest a reversal in the near term.

Recent contract announcement with a major U.S. automaker for a Driver Monitoring System, which boosted the stock price by over 5%.
Positive sentiment around autonomous driving technology, as seen in related industry developments.
Insider selling has increased significantly (94071.64% over the last month), indicating potential lack of confidence from within the company.
Mixed to negative analyst sentiment with multiple downgrades and lowered price targets, citing headwinds from elevated R&D expenses and OEM insourcing.
Weak financial performance in Q4 2025, with an 8.98% YoY revenue decline and negative net income despite some improvement in EPS.
In Q4 2025, Mobileye's revenue dropped by 8.98% YoY to $446M. Net income improved but remained negative at -$127M, up 78.87% YoY. EPS also improved to -$0.16, up 77.78% YoY. Gross margin declined to 45.29%, down 7.91% YoY. The company's guidance for FY26 indicates modest revenue growth of 3% YoY, below market expectations.
Analyst sentiment is mixed to negative. Tigress Financial maintains a Buy rating with a $25 price target, citing long-term potential in ADAS and robotaxi platforms. However, multiple firms, including UBS, HSBC, and Morgan Stanley, have downgraded the stock or lowered price targets, citing near-term headwinds, elevated R&D expenses, and weaker-than-expected guidance.